XEME Biopharma Holdings Inc. — Regulation A 1-A POS
XEME Biopharma Holdings Inc. of Irvine, CA filed a Regulation A 1-A POS with the SEC on 2020-12-22. Aggregate offering: $20.0M (Tier 2). Industry: Other.
Offering
- Filed: 2020-12-22
- Form: 1-A POS
- Accession: 0001775196-20-000013
- Tier: Tier 2
- Total aggregate offering: $20.0M
- Issuer portion: $20.0M
- Price per security: $0.2000
- Securities offered: Equity (common or preferred stock)
- Audit status: Audited
- Auditor: Raymond & KO
- Jurisdictions: 64 states/territories
Issuer
- CIK: 0001775196
- Organized in: FL
- Incorporated: 2019
- Address: 20 Corporate Park, Irvine, CA, 92606
- Phone: 657-269-3883
- Employees: 3 full-time, 3 part-time
Financial snapshot (as filed)
- Total assets: $1.1M
- Cash & equivalents: $542K
- Total liabilities: $1.1M
- Stockholder equity: $49K
- Net income: $-450K
People (2)
| Name | Role | Location |
|---|
| Indrajith Andrew Weeraratne | Signer | MIAMI BEACH, FL |
| Andrew Weeraratne | Signer | Miami Beach, FL |
Other Reg A filings by this issuer (10)
More